Updated on Jan 26, 2017 | Inside, Research
Promising new treatments for Sickle cell disease are on the horizon for this chronic disease, which, though not immediately fatal, can cause complications that dramatically affect patients’ day-to-day lives. Learn more in this post from the Huffington Post by Jeffrey Glassberg, MD, MA, Assistant Professor of Emergency Medicine, Hematology and Medical Oncology and Associate Director of The Mount Sinai Comprehensive Sickle Cell Program at the Icahn School of Medicine at Mount Sinai. Read more
Dec 13, 2016 | Inside, Your Health
Hemangiomas are the most common type of birthmark in children. While all start off small, some can grow quite large and they can alter the surrounding soft tissues and structures in ways that will not go away on their own. That is one reason it’s important for hemangiomas to be diagnosed and treated while infants are very young, Gregory M. Levitin, MD (www.birthmarkcare.com) is Director, Vascular Birthmarks and Malformations, and Associate Clinical Professor of Otolaryngology/Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, writes in The New York Daily News. Read more
Dec 2, 2016 | Featured, Inside, Research, School
Keynote Speaker George Church, PhD, Professor of Genetics, Harvard Medical School
The increasingly important role that academic medical centers play in the discovery of treatments for human diseases was the central theme of the Fifth Annual SinaInnovations conference held Tuesday, October 25, and Wednesday, October 26, at the Icahn School of Medicine at Mount Sinai. (more…)
Updated on Jun 30, 2022 | Community, Inside, Patient Stories
Three “generations” of mentors for Woman to Woman, a group that supports women with gynecologic cancer: from left, Robin Findling, Myrtice Wooten, and Tricia Clarke.
It was something of a family reunion when cancer survivors met on a recent Saturday at the 92nd Street Y—if a family can consist of 100 women from just about every generation and culture. What they had in common was Woman to Woman, a peer-to-peer program founded at Mount Sinai by Valerie Goldfein, an ovarian cancer survivor, that provides emotional support, mentoring, and financial aid to women in treatment for gynecologic cancer. (more…)
Updated on Jun 30, 2022 | Community, Inside
Julius H. Jacobson II, MD, left, with Michael L. Marin, MD
Mount Sinai surgeons, staff, and guests recently celebrated the opening of one of New York State’s first Aortic Disease Centers, which was established through the generous support of Julius H. Jacobson II, MD, Director Emeritus of Vascular Surgery and Distinguished Service Professor of Surgery at Mount Sinai, and his wife, Joan Jacobson. The Julius and Joan Jacobson Aortic Disease Center will be devoted to improving overall patient care and education, and advancing research and treatment efforts, including preventive strategies, for aortic aneurysms and other diseases of the aorta. Mount Sinai has long been a leader in developing new techniques and minimally invasive treatments for the repair of aortic aneurysms, which alone claim the lives of nearly 20,000 Americans each year. (more…)
Nov 24, 2016 | Inside, Patient Stories
Patient Evan Wood, left, at the New York City Marathon with Keith J. Benkov, MD
Evan Wood, a 22-year-old Mount Sinai patient, won the Foot Locker Five-Borough Challenge at the New York City Marathon, representing Manhattan and Team IBDKids, a cause that is deeply meaningful to him. Mr. Wood, a recent graduate of New York University, was diagnosed with Crohn’s disease when he was 14, struggling with stomach pain and weighing about 80 pounds. With care from doctors at The Mount Sinai Hospital, including Keith J. Benkov, MD, he began to thrive. And inspired by Dr. Benkov, who has finished 29 New York marathons, he took up running. “He’s modest, and he doesn’t like praise,” Mr. Wood says of Dr. Benkov, “but he’s been a miracle for me; he’s been a lifesaver.” Dr. Benkov started and leads Team IBDKids, which supports The Children’s Inflammatory Bowel Disease Program at Mount Sinai. The team has raised more than $200,000 this year, and $3 million since starting in 2006, Dr. Benkov says. At the marathon on Sunday, November 6, Mr. Wood raised $3,163 while winning the Challenge, a “race-within-a-race” against four other runners, each representing a borough and a charity. They started together, but competition began in earnest at the halfway point, just outside of Queens. “It’s a very good-spirited competition,” says Mr. Wood, whose race time was 3:44:57. “And you get citywide bragging rights.”
Promising new treatments for Sickle cell disease are on the horizon for this chronic disease, which, though not immediately fatal, can cause complications that dramatically affect patients’ day-to-day lives. Learn more in this post from the Huffington Post by Jeffrey Glassberg, MD, MA, Assistant Professor of Emergency Medicine, Hematology and Medical Oncology and Associate Director of The Mount Sinai Comprehensive Sickle Cell Program at the Icahn School of Medicine at Mount Sinai. Read more
